BR0315623A - Tetralinas e indanos substituìdos - Google Patents
Tetralinas e indanos substituìdosInfo
- Publication number
- BR0315623A BR0315623A BR0315623-0A BR0315623A BR0315623A BR 0315623 A BR0315623 A BR 0315623A BR 0315623 A BR0315623 A BR 0315623A BR 0315623 A BR0315623 A BR 0315623A
- Authority
- BR
- Brazil
- Prior art keywords
- indans
- substituted tetralines
- tetralines
- substituted
- tetralin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/56—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42002602P | 2002-10-21 | 2002-10-21 | |
US49578803P | 2003-08-15 | 2003-08-15 | |
PCT/US2003/033371 WO2004037779A1 (en) | 2002-10-21 | 2003-10-17 | Substituted tetralins and indanes and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0315623A true BR0315623A (pt) | 2005-08-23 |
Family
ID=32179777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0315623-0A BR0315623A (pt) | 2002-10-21 | 2003-10-17 | Tetralinas e indanos substituìdos |
Country Status (28)
Country | Link |
---|---|
US (2) | US20040167211A1 (pt) |
EP (1) | EP1554240B1 (pt) |
JP (1) | JP4411275B2 (pt) |
KR (1) | KR100989394B1 (pt) |
CN (1) | CN100354259C (pt) |
AT (1) | ATE430728T1 (pt) |
AU (1) | AU2003279996B2 (pt) |
BR (1) | BR0315623A (pt) |
CA (1) | CA2502665A1 (pt) |
CY (1) | CY1110326T1 (pt) |
DE (1) | DE60327543D1 (pt) |
DK (1) | DK1554240T3 (pt) |
EA (1) | EA009554B1 (pt) |
ES (1) | ES2325783T3 (pt) |
HR (1) | HRP20050336B1 (pt) |
IL (1) | IL168147A (pt) |
ME (1) | MEP53108A (pt) |
MX (1) | MXPA05004192A (pt) |
NO (1) | NO332352B1 (pt) |
NZ (1) | NZ539451A (pt) |
PL (1) | PL376326A1 (pt) |
PT (1) | PT1554240E (pt) |
RS (1) | RS52079B (pt) |
SI (1) | SI1554240T1 (pt) |
TW (1) | TWI308563B (pt) |
UA (1) | UA80561C2 (pt) |
WO (1) | WO2004037779A1 (pt) |
ZA (1) | ZA200504064B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060247314A1 (en) * | 2002-10-21 | 2006-11-02 | Xiaoli Chen | Substituted tetralins and indanes |
US20060094786A1 (en) * | 2002-10-21 | 2006-05-04 | Xiaoli Chen | Treating syndrome X with substituted tetralins and indanes |
NZ539510A (en) * | 2002-10-21 | 2008-01-31 | Janssen Pharmaceutica Nv | Substituted tetralin and indane derivatives |
PL376470A1 (en) * | 2002-10-21 | 2005-12-27 | Janssen Pharmaceutica N.V. | Treating syndrome x with substituted tetralins and indanes |
AR048931A1 (es) * | 2004-04-21 | 2006-06-14 | Janssen Pharmaceutica Nv | Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis |
CA2583454A1 (en) * | 2004-10-12 | 2006-04-27 | Pharmacopeia Drug Discovery, Inc. | Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
CA2898534C (en) * | 2013-03-20 | 2017-09-19 | F. Hoffmann-La Roche Ag | Urea derivatives and their use as fatty-acid binding protein (fabp) inhibitors |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU632809B2 (en) * | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
GB9027023D0 (en) | 1990-12-12 | 1991-01-30 | Wellcome Found | Anti-atherosclerotic aryl compounds |
JP3342491B2 (ja) | 1993-08-06 | 2002-11-11 | ファルマシア・アンド・アップジョン・カンパニー | 選択的ドーパミンd3リガンドとしての2−アミノインダン類 |
GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
WO1997047738A1 (fr) | 1996-06-13 | 1997-12-18 | Fujisawa Pharmaceutical Co., Ltd. | Acylase des lipopeptides cycliques |
GB9822473D0 (en) * | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
US6300339B1 (en) | 1998-10-21 | 2001-10-09 | Novo Nordisk A/S | Compounds, their preparation and use |
TWI234557B (en) | 1999-05-26 | 2005-06-21 | Telik Inc | Novel naphthalene ureas as glucose uptake enhancers |
CA2400021A1 (en) * | 2000-02-18 | 2001-08-23 | Merck & Co., Inc. | Aryloxyacetic acids for diabetes and lipid disorders |
SK4132003A3 (en) * | 2000-10-05 | 2004-02-03 | Bayer Ag | Propionic acid derivatives, the process for their preparation, pharmaceutical composition comprising them, use thereof and intermediates for producing them |
WO2002044129A1 (fr) * | 2000-11-29 | 2002-06-06 | Kyorin Pharmaceutical Co., Ltd. | Dérivés d'acide carboxylique substitués |
AU2002222573A1 (en) * | 2000-12-05 | 2002-06-18 | Kyorin Pharmaceutical Co. Ltd. | Substituted carboxylic acid derivatives |
AU2002233271A1 (en) * | 2000-12-20 | 2002-07-01 | Glaxo Group Limited | Substitued oxazoles and thiazoles as hppar alpha agonists |
TWI241190B (en) | 2001-02-13 | 2005-10-11 | Aventis Pharma Gmbh | 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical |
CA2438551A1 (en) | 2001-02-15 | 2002-08-22 | Pfizer Products Inc. | Ppar agonists |
WO2002064130A1 (en) | 2001-02-15 | 2002-08-22 | Pfizer Products Inc. | Proliferative activator receptor (ppar) compounds |
US6548538B2 (en) | 2001-05-22 | 2003-04-15 | Bayer Aktiengesellschaft | Propionic acid derivatives |
UA82835C2 (en) * | 2001-12-03 | 2008-05-26 | Reddys Lab Ltd Dr | ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon |
US20060094786A1 (en) * | 2002-10-21 | 2006-05-04 | Xiaoli Chen | Treating syndrome X with substituted tetralins and indanes |
US20060247314A1 (en) * | 2002-10-21 | 2006-11-02 | Xiaoli Chen | Substituted tetralins and indanes |
NZ539510A (en) * | 2002-10-21 | 2008-01-31 | Janssen Pharmaceutica Nv | Substituted tetralin and indane derivatives |
PL376470A1 (en) * | 2002-10-21 | 2005-12-27 | Janssen Pharmaceutica N.V. | Treating syndrome x with substituted tetralins and indanes |
AR048931A1 (es) * | 2004-04-21 | 2006-06-14 | Janssen Pharmaceutica Nv | Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis |
-
2003
- 2003-10-17 KR KR1020057006805A patent/KR100989394B1/ko active IP Right Grant
- 2003-10-17 RS YU20050320A patent/RS52079B/sr unknown
- 2003-10-17 AU AU2003279996A patent/AU2003279996B2/en not_active Ceased
- 2003-10-17 ME MEP-531/08A patent/MEP53108A/xx unknown
- 2003-10-17 BR BR0315623-0A patent/BR0315623A/pt not_active IP Right Cessation
- 2003-10-17 JP JP2005501641A patent/JP4411275B2/ja not_active Expired - Fee Related
- 2003-10-17 WO PCT/US2003/033371 patent/WO2004037779A1/en active Application Filing
- 2003-10-17 PL PL03376326A patent/PL376326A1/xx not_active Application Discontinuation
- 2003-10-17 EA EA200500516A patent/EA009554B1/ru not_active IP Right Cessation
- 2003-10-17 PT PT03773302T patent/PT1554240E/pt unknown
- 2003-10-17 AT AT03773302T patent/ATE430728T1/de active
- 2003-10-17 MX MXPA05004192A patent/MXPA05004192A/es active IP Right Grant
- 2003-10-17 CA CA002502665A patent/CA2502665A1/en not_active Abandoned
- 2003-10-17 ES ES03773302T patent/ES2325783T3/es not_active Expired - Lifetime
- 2003-10-17 SI SI200331635T patent/SI1554240T1/sl unknown
- 2003-10-17 US US10/688,379 patent/US20040167211A1/en not_active Abandoned
- 2003-10-17 UA UAA200503454A patent/UA80561C2/uk unknown
- 2003-10-17 EP EP03773302A patent/EP1554240B1/en not_active Expired - Lifetime
- 2003-10-17 DE DE60327543T patent/DE60327543D1/de not_active Expired - Lifetime
- 2003-10-17 CN CNB2003801060885A patent/CN100354259C/zh not_active Expired - Fee Related
- 2003-10-17 DK DK03773302T patent/DK1554240T3/da active
- 2003-10-17 NZ NZ539451A patent/NZ539451A/en not_active IP Right Cessation
- 2003-10-21 TW TW092129193A patent/TWI308563B/zh not_active IP Right Cessation
-
2005
- 2005-04-14 HR HRP20050336AA patent/HRP20050336B1/hr not_active IP Right Cessation
- 2005-04-19 IL IL168147A patent/IL168147A/en unknown
- 2005-05-10 NO NO20052280A patent/NO332352B1/no not_active IP Right Cessation
- 2005-05-19 ZA ZA200504064A patent/ZA200504064B/en unknown
- 2005-06-03 US US11/145,119 patent/US7351857B2/en not_active Expired - Lifetime
-
2009
- 2009-08-04 CY CY20091100820T patent/CY1110326T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052277L (no) | Behandling av syndrom X med substituerte tetraliner og indaner | |
CY1110326T1 (el) | Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους | |
RS52780B (en) | MEANS OF PREVENTION AND TREATMENT OF DISORDERS CONCERNING MODULATION OF RYR RECEPTORS | |
EA200601553A1 (ru) | Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды | |
EA200900828A1 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
CY1110555T1 (el) | 4-((φαινοξυαλκυλ)θειο)-φαινοξυοξεικα οξεα και αναλογα | |
ECSP088316A (es) | Moduladores sustituidos de 3-amido-tetrahidro-indazolil cannabinoide | |
ATE421518T1 (de) | Dihydrochinazolinone als 5ht-modulatoren | |
TW200724140A (en) | Hydantoin compounds | |
TW200624117A (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
IN2015DN03331A (pt) | ||
TW200621692A (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
ATE433458T1 (de) | Modulatoren von ship-1 | |
NO20052199L (no) | Substituerte tetraliner og indaner | |
TW200738244A (en) | 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof | |
ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
DE60326348D1 (de) | Makrozyclen zur behandlung von krebserkrankungen | |
ECSP066623A (es) | Bencimidazol-, benztriazol-, y bencimidazolona-o-glucosidos sustituidos | |
SE0301794D0 (sv) | New use III | |
EA200600183A1 (ru) | Сочетание ингибитора обратного захвата серотонина и агомелатина | |
ECSP066627A (es) | Indazol-o-glucosidos sustituidos | |
UA3515U (uk) | Застосування перекису водню для профілактики сапролегніозу ікри риб | |
NO20061427L (no) | Kombinasjonen av en serotonin-reoppttaksinhibitor og amoxapin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: JOHNSON AND JOHNSON (US) Free format text: TRANSFERIDO DE: JANSSEN PHARMACEUTICA N.V. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. C07C 323/52, 323/61, 275/34, 271/56; A61K 31/16; A61P 3/00 Ipc: C07C 323/52 (2011.01), C07C 323/61 (2011.01), C07C |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |